Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018140589) EXTENDED RELEASE METHAZOLAMIDE FORMULATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/140589 International Application No.: PCT/US2018/015210
Publication Date: 02.08.2018 International Filing Date: 25.01.2018
IPC:
A61K 31/155 (2006.01) ,A61K 31/433 (2006.01) ,A61K 35/39 (2015.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
155
Amidines (), e.g. guanidine (H2N-C(NH)-NH2), isourea (HNC(OH)NH2), isothiourea (HNC(SH)-NH2)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
433
Thiadiazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
12
Materials from mammals or birds
37
Digestive system
39
Pancreas
Applicants:
EFFCON LABORATORIES, INC. [US/US]; 1165 Allgood Road Suite 24 Marietta, Georgia 30062, US
Inventors:
RIZK, Nabil; US
Agent:
WARREN, William L.; US
WIGLEY, David E.; US
PAPPAS, Peter G.; US
GRIFFIN, III, Malvern U.; US
KING, Kevin W.; US
CHAN, Christopher J.; US
SEEGER, Richard A.; US
Priority Data:
15/621,29813.06.2017US
62/450,23325.01.2017US
Title (EN) EXTENDED RELEASE METHAZOLAMIDE FORMULATION
(FR) PRÉPARATION DE MÉTHAZOLAMIDE À LIBÉRATION PROLONGÉE
Abstract:
(EN) A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
(FR) L'invention concerne une forme galénique de méthazolamide, à administration par voie orale, à libération contrôlée, de prise quotidienne unique. La forme galénique comprend une quantité thérapeutiquement efficace de méthazolamide et un liant à poids moléculaire élevé. La forme galénique est conçue pour une prise journalière unique par un sujet en ayant besoin, et libère de la méthazolamide sur une période d'environ vingt-quatre heures.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)